Evaluating Disparities in Precision Oncology

Description

This is a non-randomized observational trial designed to collect detailed clinical, social determinant, and genomic data from patients enrolled in molecular oncology tumor boards across four comprehensive cancer centers.

Conditions

Metastatic Cancer, Advanced Cancer

Talk to us

Study Overview

On this page

Study Details

Study overview

This is a non-randomized observational trial designed to collect detailed clinical, social determinant, and genomic data from patients enrolled in molecular oncology tumor boards across four comprehensive cancer centers.

Evaluating Disparities in Precision Oncology: an Observational Trial in the Context of a Real-World Academic Practice Model

Evaluating Disparities in Precision Oncology

Condition
Metastatic Cancer
Intervention / Treatment

-

Contacts and Locations

Indianapolis

Indiana University Health Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana, United States, 46202

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Ability to provide written informed consent and HIPAA authorization
  • 2. Patients must be ≥ 18 years old at the time of consent
  • 3. Patients planning to undergo molecular testing as part of their routine cancer care

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Indiana University,

Bryan P Schneider, MD, PRINCIPAL_INVESTIGATOR, Indiana University

Study Record Dates

2028-12